We are investigating whether taking ibrutinib intermittently can improve outcomes for people with chronic lymphocytic leukemia. This study aims to find out if this approach is effective compared to continuous treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the blood and bone marrow, leading to the overproduction of abnormal lymphocytes, which can cause symptoms like fatigue, swollen lymph nodes, and frequent infections.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.